孟令浩;耿曼英;闫保星;

• 1:郑州市第二人民医院
• 2:郑州大学第二附属医院

摘要(Abstract)：

目的观察糖皮质激素不同给药方式治疗贝尔面瘫的临床疗效。方法将贝尔面瘫120例患者随机分为3组各40例,A组(常规治疗组)给予常规药物、红外线理疗治疗,B组(静滴组)及C组(耳后注射组)在常规治疗的基础上分别加用糖皮质激素静滴及耳后乳突区注射糖皮质激素,3组疗程均为15 d,观察3组临床疗效。结果 A组总有效率为70.0%,B组为92.5%,C组为90.0%,A组分别与B组、C组比较差异均有统计学意义(P<0.05),B组、C组比较差异无统计学意义(P>0.05)。结论糖皮质激素早期应用于贝尔面瘫治疗,可迅速减轻面神经水肿,有利于疾病恢复。耳后局部注射糖皮质激素与全身用药效果相当,不良反应较低,值得临床推荐。

关键词(KeyWords)： 贝尔面瘫;面神经水肿;糖皮质激素;给药方式;耳后注射;全身用药

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 孟令浩;耿曼英;闫保星;

参考文献(References)：

• [1] LEE S M,LEE S,PARK J H,et al.A close look at an integrative treatment package for Bell's palsy in Korea[J].Complement Ther Clin Pract,2017,26:76-83.Doi:10.1016/j.ctcp.2016.12.003.
• [2] ZHAO H,ZHANG X,TANG Y D,et al.Bell's Palsy:Clinical Analysis of 372 Cases and Review of Related Literature[J].Eur Neurol,2017,77(3/4):168-172.DOI:10.1159/000455073.
• [3] ERDUR H,ERNST S,AHMADI M,et al.Evidence for Seasonal Variation of Bell's Palsy in Germany[J].Neuroepidemiology,2018,51(3):128-130.DOI:10.1159/000492097.
• [4] ZHANG W,XU L,LUO T,et al.The etiology of Bell’s palsy:a review[J].J Neurol,2019,16(1):47-59.DOI:10.1007/s00415-019-09282-4.
• [5] GHOSH S K,NARAYAN R K.Variations in the morphology of stylomastoid foramen:A possible solution to the conundrum of unexplained cases of Bell's palsy[J].Folia Morphol(Warsz),2020,12(3):34-42.DOI:10.5603/FM.a2020.0019.
• [6] FURUKAWA T,ABE Y,ITO T,et al.Benefits of High-dose SteroidHespanderMannitol Administration in the Trea-tment of Bell's Palsy[J].Otol Neurotol,2017,38(2):272-277.DOI:10.1097/MAO.0000000000001307.
• [7] SEVIK ELICORA S,ERDEM D.Does Type 2 Diabetes Mellitus Affect the Healing of Bell's Palsy in Adults?[J].Can J Diabetes,2018,42(4):433-436.DOI:10.1016/j.jcjd.2017.10.055.
• [8] FUJIWARA T,NAMEKAWA M,KURIYAMA A,et al.High-dose Corticosteroids for Adult Bell's Palsy:Systematic Review and Meta-analysis[J].Otol Neurotol,2019,40(8):1101-1108.DOI:10.1097/MAO.0000000000002317.
• [9] MANCINI P,BOTTARO V,CAPITANI F,et al.Recurrent Bell's palsy:outcomes and correlation with clinical comorbidities[J].Acta Otorhinolaryngol Italica,2019,39(5):316-321.DOI:10.14639/0392-100X-2415.
• [10] INAGAKI A,MINAKATA T,KATSUM S,et al.Concurrent Treatment With Intratympanic Dexamethasone for Moderate-Severe Through Severe Bell’s Palsy[J].Otol Neurotol,2019,40(10):e1018-e1023.DOI:10.1097/MAO.0000000000002377.
• [11] BAUGH R F,BASURA G J,ISHII L E,et al.clinical practice guideline:Bell’s Palsy[J].Otolaryngol Head Neck Surg,2013,149(3 Suppl):S1-S27.DOI:10.1177/0194599813505967.
• [12] 孟令浩,朱瑞丽,耿曼英,等.高压氧治疗贝尔面瘫中的临床观察[J].中国实用神经疾病杂志,2017,20(5):64-66.DOI:10.3969/j.issn.1673-5110.2017.05.023.
• [13] GENIZI J,GOLAN-SHANG O,TARAZOV T,et al.Does Herpes 6 Infection Have a Role in Bell's Palsy Among Children and Adolescents?[J].Pediatr Infect Dis J,2019,38(5):481-483.DOI:10.1097/INF.0000000000002278.
• [14] KARATOPRAK E,YILMAZ S.Prognostic Factors Associated With Recovery in Children With Bell's Palsy[J].J Child Neurol,2019,34(14):891-896.DOI:10.1177/0883073819865672.
• [15] ARICAN P,DUNDAR N O,GENCOINAR P,et al.Efficacy of Low-Dose Corticosteroid Therapy Versus High-Dose Corticosteroid Therapy in Bell's Palsy in Children[J].J Child Neurol,2017,32(1):72-75.DOI:10.1177/0883073816668774.
• [16] YOO H W,YOON L,KIM H Y,et al.Comparison of conservative therapy and steroid therapy for Bell's palsy in children[J].Korean J Pediatr,2018,61(10):332-337.DOI:10.3345/kjp.2018.06380.
• [17] DEMIR D,GENC S,GUVEN M,et al.Intratympanic Steroid Treatment of Bell’s Palsy in Patients with Comorbid Disease:A Preliminary Report[J].J Int Adv Otol,2020,16(1):47-52.DOI:10.5152/iao.2019.5415.